95 related articles for article (PubMed ID: 22243776)
1. FOXP3(+) regulatory and TIA-1(+) cytotoxic T lymphocytes in HIV-associated Hodgkin lymphoma.
Kiyasu J; Aoki R; Tanaka PY; Pracchia LF; Calore EE; Perez NM; Kimura Y; Niino D; Sugita Y; Takayanagi R; Abe Y; Matsuoka M; Ohshima K
Pathol Int; 2012 Feb; 62(2):77-83. PubMed ID: 22243776
[TBL] [Abstract][Full Text] [Related]
2. Decreased number of granzyme B+ activated CD8+ cytotoxic T lymphocytes in the inflammatory background of HIV-associated Hodgkin's lymphoma.
Bosch Príncep R; Lejeune M; Salvadó Usach MT; Jaén Martínez J; Pons Ferré LE; Alvaro Naranjo T
Ann Hematol; 2005 Oct; 84(10):661-6. PubMed ID: 15875183
[TBL] [Abstract][Full Text] [Related]
3. Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.
Quesada AE; Assylbekova B; Jabcuga CE; Zhang R; Covinsky M; Rios A; Nguyen ND; Brown RE
Int J Clin Exp Pathol; 2015; 8(10):13241-8. PubMed ID: 26722524
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
[TBL] [Abstract][Full Text] [Related]
5. Comparative flow immunophenotypic features of the inflammatory infiltrates of Hodgkin lymphoma and lymphoid hyperplasia.
Hudnall SD; Betancourt E; Barnhart E; Patel J
Cytometry B Clin Cytom; 2008 Jan; 74(1):1-8. PubMed ID: 18061945
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's reed-sternberg cell line (KM-H2) promotes a bidirectional differentiation of CD4+CD25+Foxp3+ T cells and CD4+ cytotoxic T lymphocytes from CD4+ naive T cells.
Tanijiri T; Shimizu T; Uehira K; Yokoi T; Amuro H; Sugimoto H; Torii Y; Tajima K; Ito T; Amakawa R; Fukuhara S
J Leukoc Biol; 2007 Sep; 82(3):576-84. PubMed ID: 17545218
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus and Hodgkin's lymphoma.
Andersson J
Herpes; 2006 May; 13(1):12-6. PubMed ID: 16732997
[TBL] [Abstract][Full Text] [Related]
8. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
Alvaro T; Lejeune M; Salvadó MT; Bosch R; García JF; Jaén J; Banham AH; Roncador G; Montalbán C; Piris MA
Clin Cancer Res; 2005 Feb; 11(4):1467-73. PubMed ID: 15746048
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated Hodgkin lymphoma: a clinicopathologic and immunophenotypic study of 45 cases.
Thompson LD; Fisher SI; Chu WS; Nelson A; Abbondanzo SL
Am J Clin Pathol; 2004 May; 121(5):727-38. PubMed ID: 15151213
[TBL] [Abstract][Full Text] [Related]
10. [Epstein-Barr virus presence in Colombian Hodgkin lymphoma cases and its relation to treatment response].
Quijano S; Saavedra C; Fiorentino S; Orozco O; Bravo MM
Biomedica; 2004 Jun; 24(2):163-73. PubMed ID: 15495596
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies.
Teramoto N; Sarker AB; Tonoyama Y; Yoshino T; Hayashi K; Takahashi K; Akagi T
Cancer; 1996 Jun; 77(11):2339-47. PubMed ID: 8635105
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotype of skin lymphocytic infiltrate in patients co-infected with Mycobacterium leprae and human immunodeficiency virus: a scenario dependent on CD8+ and/or CD20+ cells.
Massone C; Talhari C; Talhari S; Brunasso AM; Campbell TM; Curcic P; Cerroni L; Ribeiro-Rodrigues R
Br J Dermatol; 2011 Aug; 165(2):321-8. PubMed ID: 21574977
[TBL] [Abstract][Full Text] [Related]
13. Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques.
Blaschke S; Hannig H; Buske C; Kaup FJ; Hunsmann G; Bodemer W
J Med Virol; 2001 Sep; 65(1):114-20. PubMed ID: 11505452
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP
Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus in biopsies from patients with Hodgkin and non-Hodgkin lymphoma at the University of Puerto Rico immunohistochemistry laboratory.
Córdova Pérez FJ; González-Keelan CI; Vélez R
P R Health Sci J; 2003 Jun; 22(2):125-9. PubMed ID: 12866135
[TBL] [Abstract][Full Text] [Related]
17. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of cyclin a correlates with morphogenesis of reed-sternberg cells in Hodgkin lymphoma.
Chang KC; Chang Y; Jones D; Su IJ
Am J Clin Pathol; 2009 Jul; 132(1):50-9. PubMed ID: 19864233
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype.
Chang KC; Khen NT; Jones D; Su IJ
Hum Pathol; 2005 Jul; 36(7):747-55. PubMed ID: 16084943
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrated immune response correlates with alterations in the apoptotic and cell cycle pathways in Hodgkin and Reed-Sternberg cells.
Alvaro T; Lejeune M; García JF; Salvadó MT; López C; Bosch R; Jaén J; Escrivá P; Pons LE
Clin Cancer Res; 2008 Feb; 14(3):685-91. PubMed ID: 18245527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]